Telesis Bio (TBIO) Competitors $0.05 0.00 (0.00%) As of 06/10/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock TBIO vs. SMIT, SPEC, THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, and KEYSShould you be buying Telesis Bio stock or one of its competitors? The main competitors of Telesis Bio include Schmitt Industries (SMIT), Spectaire (SPEC), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), and Keysight Technologies (KEYS). These companies are all part of the "measuring and control equipment" industry. Telesis Bio vs. Its Competitors Schmitt Industries Spectaire ThermoGenesis HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Telesis Bio (NASDAQ:TBIO) and Schmitt Industries (NASDAQ:SMIT) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, community ranking, dividends, institutional ownership, analyst recommendations, earnings and valuation. Does the MarketBeat Community prefer TBIO or SMIT? Schmitt Industries received 85 more outperform votes than Telesis Bio when rated by MarketBeat users. Likewise, 55.29% of users gave Schmitt Industries an outperform vote while only 52.94% of users gave Telesis Bio an outperform vote. CompanyUnderperformOutperformTelesis BioOutperform Votes952.94% Underperform Votes847.06% Schmitt IndustriesOutperform Votes9455.29% Underperform Votes7644.71% Which has higher earnings and valuation, TBIO or SMIT? Schmitt Industries has lower revenue, but higher earnings than Telesis Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTelesis Bio$225.09M0.00-$47.72M-$28.200.00Schmitt Industries$9.89M0.01-$3.28MN/AN/A Which has more risk & volatility, TBIO or SMIT? Telesis Bio has a beta of 1.42, suggesting that its stock price is 42% more volatile than the S&P 500. Comparatively, Schmitt Industries has a beta of -0.29, suggesting that its stock price is 129% less volatile than the S&P 500. Is TBIO or SMIT more profitable? Schmitt Industries has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Company Net Margins Return on Equity Return on Assets Telesis Bio-336.59% N/A -61.89% Schmitt Industries N/A N/A N/A Do insiders and institutionals believe in TBIO or SMIT? 37.6% of Telesis Bio shares are held by institutional investors. 24.5% of Telesis Bio shares are held by insiders. Comparatively, 17.1% of Schmitt Industries shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media favor TBIO or SMIT? In the previous week, Telesis Bio had 1 more articles in the media than Schmitt Industries. MarketBeat recorded 1 mentions for Telesis Bio and 0 mentions for Schmitt Industries. Telesis Bio's average media sentiment score of 1.00 beat Schmitt Industries' score of 0.00 indicating that Telesis Bio is being referred to more favorably in the media. Company Overall Sentiment Telesis Bio Positive Schmitt Industries Neutral SummaryTelesis Bio and Schmitt Industries tied by winning 6 of the 12 factors compared between the two stocks. Get Telesis Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TBIO vs. The Competition Export to ExcelMetricTelesis BioAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$90K$4.59B$5.57B$8.62BDividend YieldN/A0.55%5.28%4.18%P/E Ratio0.0025.0227.1120.06Price / Sales0.003.89409.88157.10Price / CashN/A36.3438.2534.64Price / Book0.361.677.064.70Net Income-$47.72M-$82.28M$3.23B$247.88M7 Day PerformanceN/A6.12%2.88%2.66%1 Month PerformanceN/A11.47%9.04%6.40%1 Year PerformanceN/A-11.37%31.40%14.07% Telesis Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TBIOTelesis Bio1.4745 of 5 stars$0.05flatN/A-98.4%$90K$225.09M0.00200Positive NewsShort Interest ↓SMITSchmitt IndustriesN/A$0.02flatN/AN/A$82K$9.89M0.00160SPECSpectaireN/A$0.00-47.6%N/A-99.7%$20KN/A0.008Gap DownTHMOThermoGenesisN/AN/AN/AN/A$1K$9.61M0.0040HTGMQHTG Molecular DiagnosticsN/AN/AN/A-96.0%$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.06-7.7%N/A-27.9%$0.00N/A0.003PRENWPrenetics GlobalN/A$0.01+8.8%N/A+28.1%$0.00$30.62M0.001Positive NewsShort Interest ↓Gap UpQSIAWQuantum-SiN/A$0.79-1.8%N/A+300.6%$0.00$3.44M0.00150Gap UpSMAPWSportsMap Tech AcquisitionN/A$0.05flatN/A+16.4%$0.00N/A0.00N/ATTTrane Technologies4.3924 of 5 stars$430.33+0.0%$427.47-0.7%+30.1%$95.97B$20.31B38.2539,000Positive NewsDividend AnnouncementKEYSKeysight Technologies4.2441 of 5 stars$158.36+0.8%$183.00+15.6%+19.4%$27.37B$5.11B45.2515,000 Related Companies and Tools Related Companies Schmitt Industries Competitors Spectaire Competitors ThermoGenesis Competitors HTG Molecular Diagnostics Competitors OmniLit Acquisition Competitors Prenetics Global Competitors Quantum-Si Competitors SportsMap Tech Acquisition Competitors Trane Technologies Competitors Keysight Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TBIO) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telesis Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telesis Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
